trial · primary record
Hepalatide 2.1mg
Hepatitis D, Chronic
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2028-08 |
| Primary endpoint | Proportion of subjects who achieved response |
| Registry ID | NCT07309380 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:30.311Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07309380
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.